|
|
|
|
|
|
|
29.01.26 - 12:31
|
Proposal of Optomed′s Nomination Board (Cision)
|
|
|
Optomed Plc Stock Exchange Release 29 January 2026 at 13:30, Helsinki
Proposal of Optomed's Nomination Board
Optomed's Nomination Board proposes the following to the next Annual General Meeting:
Number of Board members
The Nomination Board proposes, that the number of members of the Board of Directors for the term expiring at the end of the Annual General Meeting 2027 is eight.
Composition of the Board of Directors
The Nomination Board proposes to the Annual General Meeting that Sameer Badlani, Catherine Calarco, Ty Lee, Seppo Mäkinen, Petri Salonen, Reijo...
|
|
|
|
|
|
|
|
|
28.01.26 - 07:30
|
Terveystalo Q4/2025 result webcast and conference call on 13 February 2026 at 10:30 EET (Cision)
|
|
|
Terveystalo Press Release 28 January 2026
Terveystalo Plc will publish its Financial Statements Release 2025 on Friday 13 February 2026 at 9:00 EET. Materials will be available soon after publication on Terveystalo's IR website.
Terveystalo will arrange a webcast and conference call in English on the same day, starting at 10:30 EET.
You can watch the webcast online at: https://terveystalo.events.inderes.com/q4-2025
You can access the teleconference by registering at the link below.
https://events.inderes.com/terveystalo/q4-2025/dial-in
After the registration, you will be...
|
|
|
|
|
21.01.26 - 10:06
|
Optomed Achieves ISO 27001 Certification for Information Security Management Systems (Cision)
|
|
|
Optomed Plc Press Release 21 Jan 2026 at 11.00, Helsinki
Optomed Achieves ISO 27001 Certification for Information Security Management Systems
Optomed, a global leader in AI-enabled handheld retinal screening technology, is proud to announce that it has achieved ISO 27001 certification, the internationally recognized standard for Information Security Management Systems (ISMS).
ISO 27001 is a globally accepted framework for managing sensitive company and customer information, ensuring confidentiality, integrity, and availability of data through robust risk management practices...
|
|
|
|
|
|
|
|
|
15.01.26 - 17:01
|
Tuukka Paavola appointed as Chief Financial Officer of Bioretec (PR Newswire)
|
|
|
Bioretec Ltd Company announcement 15 January 2026 at 5:30 p.m. EET TAMPERE, Finland, Jan. 15, 2026 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants appoints Tuukka Paavola (M.Sc. Industrial Engineering, CFA) as Chief Financial Officer, effective 20 January 2025.......
|
|
|
|
|
|
|
14.01.26 - 09:36
|
Bayer-Partner Orion mit Top-Prognose – AKTIONÄR-Tipp geht steil (Der Aktionaer)
|
|
|
Nubeqa (Darolutamid) trifft weiterhin auf eine rege Nachfrage. Das Prostatakrebs-Medikament, welches von der finnischen Orion Corporation an das DAX-Unternehmen Bayer vor vielen Jahren auslizenziert wurde, steht vor weiterem, dynamischem Wachstum. Das unterstreicht eine Prognose, die Orion dem Kapitalmarkt am Mittwoch an die Hand gegeben hat....
|
|
|
|
|
13.01.26 - 17:27
|
Faron Pharmaceuticals Ltd: PDMR Dealing (Accesswire)
|
|
|
TURKU, FINLAND / ACCESS Newswire / January 13, 2026 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN), a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, announces ......
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
